• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

Shockwave Medical launches new coronary IVL catheter

May 15, 2023 By Sean Whooley

Shockwave-Medical-C2-Plus-IVL-Catheter
[Image from Shockwave Medical]
Shockwave Medical (Nasdaq:SWAV) today announced full commercial availability for its C2+ coronary intravascular lithotripsy (IVL) catheter.

The company designed its C2+ coronary IVL catheter to treat severely calcified coronary artery disease. Santa Clara, California-based Shockwave, which has been subject to recent acquisition speculation, launched the catheter in select international markets.

Shockwave C2+ is commercially available for the treatment of de novo coronary artery disease in Europe and select other geographies.

Last month, Bloomberg reported that Boston Scientific had eyes on acquiring Shockwave. Last week, a Streetinsider.com report claimed interest from Medtronic and Johnson & Johnson as well. The reports came from anonymous sources. Both Medtronic and Shockwave declined to comment on the speculation.

The company said in a news release that its C2+ provides 50% more pulses per catheter than the previous C2 version. Its design enables the treatment of longer calcified lesions and more challenging, eccentric and nodular calcium.

“Shockwave C2+ maintains the intuitive catheter design and ease of use that are foundational to the success of Shockwave IVL and incorporates improvements that will enhance procedural efficiency and optimize the treatment of the most challenging morphologies,” said Dr. Jonathan Hill, MD, consultant cardiologist at the Royal Brompton Hospital in London. “The extra pulses are most advantageous in areas with the highest burden of calcium, including nodular, eccentric, diffuse and multivessel calcium.”

Shockwave Medical shares clinical trial news, too

The company also announced the enrollment of the first patient in its EMPOWER CAD study. This marks the first prospective, all-female study of percutaneous coronary intervention (PCI), Shockwave said.

EMPOWER CAD aims to confirm the benefits of coronary IVL in female patients with calcified lesions. These patients historically experienced less favorable clinical outcomes than male patients with traditional therapies. Dr. Richard A. Shlofmitz of St. Francis Hospital in Roslyn, New York, enrolled the first patient.

“We are excited to initiate enrollment of the EMPOWER CAD study, the first prospective clinical study in the interventional space that is completely dedicated to female patients,” said Dr. Margaret McEntegart, director of the complex PCI Program at Columbia University Medical Center/New York-Presbyterian Hospital and co-principal investigator of EMPOWER CAD. “This is a major step towards better understanding the optimal strategy for calcium modification in female patients, an under-represented patient population who frequently are more challenging to treat and often experience suboptimal outcomes.”

Filed Under: Catheters Tagged With: Shockwave Medical

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS